Latest Conference Articles

Pimavanserin vs Off-Label Psychotics for Dementia-Related Psychosis: Clive Ballard, MD

Pimavanserin vs Off-Label Psychotics for Dementia-Related Psychosis: Clive Ballard, MD

April 20th 2021, 9:00pm

American Academy of Neurology Annual Meeting

The dean at the University of Exeter Medical School discussed the questions related to treating dementia-related psychosis and the options available.

Treatment Compliance Higher Among Ofatumumab-Treated Patients Than Teriflunomide

Treatment Compliance Higher Among Ofatumumab-Treated Patients Than Teriflunomide

April 20th 2021, 8:00pm

American Academy of Neurology Annual Meeting

Patient/guardian decision, adverse event, and physician decision were the 3 noted reasons for discontinuation with either ofatumumab or teriflunomide.

Stem Cell Therapy for Spinal Cord Injury on Pace to Soon Enter Human Phase Testing

Stem Cell Therapy for Spinal Cord Injury on Pace to Soon Enter Human Phase Testing

April 20th 2021, 6:00pm

American Academy of Neurology Annual Meeting

In an AAN plenary talk, Mark H. Tuszynski, MD, PhD, detailed the work he and colleagues have done to push stem cell therapy from the lab to the clinic to improve care for spinal cord injury.

African American Women Experience Greatest Disadvantage in Post-Stroke Rehabilitation

African American Women Experience Greatest Disadvantage in Post-Stroke Rehabilitation

April 20th 2021, 3:05pm

American Academy of Neurology Annual Meeting

Researchers analyzed disparities in stroke rehab and found that women and African Americans had the lowest functional performance.

Trends in Movement Disorder Research: Ihtsham ul Haq, MD, FAAN

Trends in Movement Disorder Research: Ihtsham ul Haq, MD, FAAN

April 20th 2021, 1:00pm

American Academy of Neurology Annual Meeting

The chief of Movement Disorders Division at the University of Miami Miller School of Medicine discussed some of the recent focused efforts to uncover more about Parkinson disease and what is on the horizon.

Fremanezumab Demonstrates Efficacy and Safety in Pair of AAN Posters

Fremanezumab Demonstrates Efficacy and Safety in Pair of AAN Posters

April 20th 2021, 11:00am

American Academy of Neurology Annual Meeting

Patients with a previous history of cardiovascular risks experienced similarly low number of cardiovascular events with treatment of fremanezumab compared with placebo.

Validated MANAGE-PD Tool May Identify Parkinson Disease Treatment Gaps

Validated MANAGE-PD Tool May Identify Parkinson Disease Treatment Gaps

April 19th 2021, 9:00pm

American Academy of Neurology Annual Meeting

In total, 50% of patients eligible for device-aided therapies did not report having any discussion with providers about future device-aided therapies.

Treatment Disparities, Neurologic Complications Clarified by COVID-19 Neurological Research

Treatment Disparities, Neurologic Complications Clarified by COVID-19 Neurological Research

April 19th 2021, 7:25pm

American Academy of Neurology Annual Meeting

The 2021 AAN Meeting Hot Topics plenary focused on neurological facets of COVID-19, and featured insight from Anthony Fauci, MD, of NIAID, and Walter Koroshetz, MD, of NINDS, among others.

Mitigating Disparities in Stroke Rehabilitation Care: Sana Somani, MD, MBBS

Mitigating Disparities in Stroke Rehabilitation Care: Sana Somani, MD, MBBS

April 19th 2021, 5:00pm

American Academy of Neurology Annual Meeting

The vascular neurology fellow at the University of Maryland Medical Center discussed strategies to improve stroke care efficiency in women and African Americans.

Deep Brain Stimulation Leads Advances in Neuromodulation for Movement Disorders

Deep Brain Stimulation Leads Advances in Neuromodulation for Movement Disorders

April 19th 2021, 3:00pm

American Academy of Neurology Annual Meeting

An AAN session included presentations of research on the latest advancements and knowledge in neuromodulation for patients with these disorders.